Canadian Court Blocks Actavis's Generic Version of Janssen's Concerta

摘要

A Canadian court granted Janssen Inc. an order to block Actavis Pharma Co. from producing a generic version of Janssen's patented attention deficit hyperactivity disorder drug Concerta (Janssen, Inc. v. Actavis Pharma Co., Can. Fed. Ct, No. 2016 FC 1361, 1/9/17).